-+ 0.00%
-+ 0.00%
-+ 0.00%

Newbury Pharmaceuticals to Upsize, Extend Maturity of Existing Loan

MT Newswires·11/19/2026 00:54:03
Listen to the news
12:54 AM EST, 11/19/2026 (MT Newswires) -- Newbury Pharmaceuticals (NEWBRY.ST) agreed with its lender, Slädens Pensionsstiftelse nr 3, to upsize and extend the maturity of its 30 million-krona loan. The loan amount will be increased to 40 million kronor, and maturity will be extended to June 30, 2028, from June 30, 2027, according to a Wednesday release. The annual interest rate will remain unchanged at 11%, payable quarterly. The revised terms also allows the Swedish pharmaceutical company to fully or partially repay the loan early on 30-day notice and without any prepayment fee. The amended agreement is subject to approval at an annual general meeting scheduled on Jan. 20, 2027.